N/A
Manufactured by Strategic Sourcing Services LLC
4,600 FDA adverse event reports analyzed
Last updated: 2026-04-15
PHENYLEPHRINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Strategic Sourcing Services LLC. The most commonly reported adverse reactions for PHENYLEPHRINE HCL include PAIN, INJURY, RENAL FAILURE, ANXIETY, UNEVALUABLE EVENT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHENYLEPHRINE HCL.
Out of 852 classified reports for PHENYLEPHRINE HCL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 4,600 FDA FAERS reports that mention PHENYLEPHRINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include PAIN, INJURY, RENAL FAILURE, ANXIETY, UNEVALUABLE EVENT, FEAR. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Strategic Sourcing Services LLC in connection with PHENYLEPHRINE HCL. Always verify the specific product and NDC with your pharmacist.